KSPHF Projected Dividend Yield
Kissei Pharmaceutical Co Ltd ( OTCBB : KSPHF )Kissei Pharmaceutical is a pharmaceutical company engaged in the research and development, manufacture and sale of pharmaceutical products. Co.'s major research and development areas are urogenital system, metabolism and endocrinology, as well as immunology and allergy. Co.'s principal products include a treatment for hyperphosphatemia "P-TOL," dysuria associated with benign prostatic hyperplasia (BPH) "Urief," a rapid onset and short acting insulin secretagogue "Glufast" and a therapeutic agent for patients with dry mouth "SALAGEN." In addition, Co., through its subsidiaries, is engaged in the development of information systems and provision of construction works. 20 YEAR PERFORMANCE RESULTS |
KSPHF Dividend History Detail KSPHF Dividend News KSPHF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |